Project Grant K99AI193231
Award Date 8/5/25
Completion Date 7/31/27
Dollars Obligated $133K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $507,000 Project Grant under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855) to the Icahn School of Medicine at Mount Sinai (ISMMS). The grant, awarded on August 7, 2025, aims to systematically investigate the interactions between metal ions and the immune system, and to develop specialized metal ion delivery systems to modulate immune responses for disease therapy. The overarching goal...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $441,375 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Children's Hospital Medical Center (UEI JZD1HLM2ZU83) to conduct research on the "Transcriptional Mechanisms of Chronic Inflammation in Genetically Diverse Tissue Macrophages." The project will focus on understanding the genetic factors and regulatory mechanisms that contribute to the development of metabolic...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $929,500 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Icahn School of Medicine at Mount Sinai (ISMMS) on July 23, 2025. The grant supports research to investigate the mechanism of action of different vaccine platforms, including mRNA-based and Newcastle Disease Virus (NDV)-based vaccines, in inducing long-lasting protective systemic and mucosal immune responses against...
- The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a Project Grant of $147,486.00 to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY. The grant, awarded on January 26, 2025, will support research to characterize the immune landscape and define the mechanisms of immune dysfunction in chronic hepacivirus infection, using the Norway rat hepacivirus (NRHV) as a model....
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, awarded a $805,375 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Icahn School of Medicine at Mount Sinai. The grant, awarded on November 20, 2024, supports a 5-year research project to elucidate the cellular tropism, receptor usage, and pathogenesis mechanisms of emerging bat-derived pararubulaviruses, which pose a potential global health...
- This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $462,981.00 to the Icahn School of Medicine at Mount Sinai to conduct research aimed at gaining a holistic understanding of the complex factors contributing to sepsis pathogenesis. The overarching goal is to determine how genetic factors work with clinical, behavioral, and social determinants of health to shape...
- This Project Grant award of $797,735 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research CFDA program, aims to elucidate the innate and adaptive immune mechanisms governing neonatal immune responses and sterile inflammation in early life. The research project will utilize a novel mouse model of allergen-induced neonatal sterile inflammation to investigate heightened innate and adaptive immune responses in neonates compared to...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $164,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Albany Medical College. The grant supports research to identify and characterize additional conformer-specific anti-I-A monoclonal antibodies (mAbs) to study the structure and function of MHC class II molecules, which are important for T cell-mediated immune responses. The research aims to address limitations in existing...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $192,268 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Icahn School of Medicine at Mount Sinai (ISMMS) to assess the effects of proposed HIV cure strategies in the gut-associated lymphoid tissue. This 5-year award, starting on August 26, 2025, aims to investigate the impact of HIV cure approaches on the viral reservoir located in the gut, as a large proportion of the...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $498,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The University of Texas Southwestern Medical Center in Dallas, Texas. This grant will support research investigating the role of a novel fungal RNA molecule, termed Fungal Stimulatory RNA (fsRNA), in modulating intestinal innate immune responses and its impact on gut inflammation. The research aims to uncover the mechanisms...